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SIRT2 regulates NF-κB dependent gene expression through
deacetylation of p65 Lys310
Abstract
NF-κB regulates the expression of a large number of target genes involved in the immune and
inflammatory response, apoptosis, cell proliferation, differentiation and survival. In this study, we
identified SIRT2 as a deacetylase of the transcription factor p65. SIRT2 is a member of the family of
sirtuins, which are NAD(+)-dependent deacetylases involved in several cellular processes. SIRT2
interacts with p65 in the cytoplasm and deacetylates p65 in vitro and in vivo at Lys310. Moreover, p65
is hyperacetylated at Lys310 in Sirt2(-/-) cells after TNFα stimulation, which results in the increase in
expression of a subset of p65 acetylation-dependent target genes. Our work provides evidence that p65
is deacetylated by SIRT2 in the cytoplasm to regulate the expression of specific NF-κB-dependent
genes.
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Introduction
Nuclear factor kappa B (NF-kB) belongs to a family of inducible
transcription factors that modulates gene expression in response to
a variety of extracellular and intracellular stimuli (Bonizzi et al.,
2004; Hoffmann and Baltimore, 2006; Perkins, 2006). NF--kB has
a crucial role in the regulation of many genes involved in mammalian
immune and inflammatory response, such as cytokines, cell adhesion
molecules, complement factors and a variety of immune receptors.
It has additionally been implicated as an important regulator of
cellular processes such as apoptosis, cell proliferation and
differentiation. The mammalian NF-kB family includes five
members, p65 (RelA), c-Rel, RelB, p105/p50 (NF-kB1) and
p100/p52 (NF-kB2), encoded by RELA, REL, RELB, NFKB1 and
NFKB2, respectively (Hayden and Ghosh, 2008). These proteins
form homo- or heterodimers. The most abundant heterodimer in the
majority of cells consists of the two subunits p65 and p50.
In most unstimulated cells, NF-kB is sequestered in the cytoplasm
as an inactive transcription factor complex through physical
association with one of the inhibitors of NF-kB (IkB, predominantly
IkBa). NF-kB induction involves the rapid activation of IKKb- and
NEMO-dependent phosphorylation and subsequent degradation of
IkB proteins. Consequently, dissociation of IkB proteins from NF-
kB unmasks the nuclear localization sequence (NLS) of p65, which
leads to nuclear translocation and binding of NF-kB to specific kB
consensus sequences in the chromatin, to regulate specific subsets
of genes (Ghosh et al., 1998; Pahl, 1999). Interestingly, one
consequence of NF-kB activation is the upregulation of IkBa gene
expression, mediated by a kB consensus sequence within the IkBa
promoter (Perez et al., 1995). Several lines of evidence suggest that
newly synthesized IkBa enters the nucleus, displaces non-chromatin
associated subunits of NF-kB, thereby mediating their export from
the nucleus and re-establishing a cytoplasmic pool of inhibited
complexes (Huang et al., 2000). Relocation of NF-kB into the
cytoplasm and attenuation of NF-kB-mediated transcriptional
activation therefore provides a feedback mechanism for modulating
the extent and duration of inflammatory responses by cells.
Nevertheless, if cells are continuously exposed to a specific stimulus,
NF-kB translocates back to the nucleus some time after the first
wave of NF-kB induction to continue with transcriptional regulation
of target genes (Hoffmann et al., 2002). The duration of the NF-kB
response depends at least in part on the stimulus applied and on the
type of cell.
NF-kB specificity is regulated at different levels in the cell
(Perkins et al., 1997). It is plausible that different stimuli induce
distinct post-translational modifications of p65, determining the
outcome of p65-mediated transcriptional events. Several post-
translational modifications on p65 have been described, the most
important ones being phosphorylation and acetylation (Perkins,
2006). Phosphorylation of p65 enhances its interaction with its
transcriptional coactivator CBP/p300 and with components of the
general transcription machinery (Zhong et al., 2002). Acetylation
of p65 was reported to modulate its DNA-binding capacity,
transcriptional activity, interaction with IkB proteins and subcellular
localization (Chen et al., 2001; Kiernan et al., 2003). We recently
showed that p65 is acetylated by p300 not only at Lys310 (K310),
but also at K314 and K315, two novel acetylation sites, and that
acetylation of K314 is important for late gene expression (Buerki
et al., 2008; Rothgiesser et al., 2010). Microarray analysis of
genetically complemented p65 knockout (–/–) cells treated with
tumor necrosis factor a (TNFa) identified specific sets of genes
differentially regulated by acetylation-deficient mutants of p65
compared with wild-type cells. Together, these results show that
site-specific p300-mediated acetylation of p65 regulates the
specificity of NF-kB-dependent gene expression.
Reversible protein acetylation is an important post-translational
modification that regulates the function of histones and many other
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Summary
NF-kB regulates the expression of a large number of target genes involved in the immune and inflammatory response, apoptosis, cell
proliferation, differentiation and survival. In this study, we identified SIRT2 as a deacetylase of the transcription factor p65. SIRT2 is
a member of the family of sirtuins, which are NAD+-dependent deacetylases involved in several cellular processes. SIRT2 interacts
with p65 in the cytoplasm and deacetylates p65 in vitro and in vivo at Lys310. Moreover, p65 is hyperacetylated at Lys310 in
Sirt2–/– cells after TNFa stimulation, which results in the increase in expression of a subset of p65 acetylation-dependent target genes.
Our work provides evidence that p65 is deacetylated by SIRT2 in the cytoplasm to regulate the expression of specific NF-kB-
dependent genes.
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proteins (Sterner and Berger, 2000). Acetylation has a rapid turnover
because of the highly dynamic equilibrium between two different
groups of enzymes: histone acetyltransferases (HATs) and histone
deacetylases (HDACs). The balance between these two activities
is key to regulate the appropriate cellular response to signals.
Mammalian HDACs are divided into four main classes based on
sequence similarity and cofactor dependency (class I–IV) (Yang
and Seto, 2007). Class III HDACs, also known as sirtuins, constitute
a special class of enzymes because of their requirement for NAD+
as a cofactor in their deacetylation reaction. During the
deacetylation reaction, nicotinamide (Nam) is cleaved from NAD+
and the acetyl group of the substrate is then transferred to ADP
ribose, generating the novel metabolite 2-O-acetyl-ADP ribose
(OAADPr) (Denu, 2003). The sirtuin family consists of seven
members in mammals (SIRT1–SIRT7) that contain a conserved
catalytic core domain comprised of approximately 275 amino
acids. They regulate a variety of cellular functions, such as genome
maintenance, longevity, and metabolism (Oberdoerffer and Sinclair,
2007; Westphal et al., 2007; Yamamoto et al., 2007). Until now, all
sirtuins, except for SIRT4, have been described to have
deacetylation (Taylor et al., 2008). The SIRT proteins exhibit
differential localization from nucleus to nucleolus, and from
cytoplasm to mitochondria (Sauve et al., 2006).
SIRT2 is the counterpart of yeast Hst2p and both proteins
localize to the cytoplasm (Perrod et al., 2001). SIRT2 was found
to bind HDAC6 and to deacetylate a-tubulin, thereby participating
in the regulation of microtubule dynamics and possibly cell cycle
progression (Dryden et al., 2003; North et al., 2003; Pandithage et
al., 2008). Presumably, SIRT2 regulates other cellular functions,
because p53, p300 and histones (H3 and H4) have been identified
as substrates (Black et al., 2008; Heltweg et al., 2006; Vaquero et
al., 2006). The apparent contradiction of a protein being
cytoplasmically located, yet exhibiting specificity for a histone
residue was resolved when SIRT2 localization was monitored
during cell cycle progression. SIRT2 localizes to the cytoplasm
throughout the cell cycle, with the exception of prophase during
G2–M transition, where it translocates to the nucleus to deacetylate
histone H4 at Lys16 (H4K16) (Vaquero et al., 2006). Moreover,
MEFs derived from Sirt2–/– mice show hyperacetylation of H4K16
during mitosis (Vaquero et al., 2006). In addition, the dynamic
analysis of the subcellular localization of SIRT2 revealed that this
enzyme shuttles continuously between the cytoplasmic and nuclear
compartments during interphase (North and Verdin, 2007).
Based on our recent findings, we extended our studies to further
elucidate the molecular regulation of p65 acetylation. Here, we
describe the characterization of SIRT2 as a deacetylase of p65.
Furthermore, gene expression analysis in SIRT2-deficient MEFs
indicates that SIRT2-mediated p65 deacetylation is implicated in
transcriptional regulation of a subset of genes.
Results
Generation and verification of a specific antibody against
acetylated p65 K310
To further assess the functional relevance of p65 acetylation in
vivo, we generated antibodies raised against acetylated K310. The
selected antibody recognized specifically p65 acetylated in vitro
and in cells by p300 at K310 (Fig. 1A,B). Furthermore, we
investigated the kinetics of p65 acetylation in response to TNFa
stimulation in cells. p65–/– MEFs stably complemented with p65
(Buerki et al., 2008) were stimulated for the indicated times (20–
90 minutes). Western blot analysis of immunoprecipitated p65
from the nuclear fraction of the cells revealed that endogenous p65
predominantly translocated after 20 minutes of TNFa treatment
into nucleus, which correlated with its acetylation at K310 (Fig.
1C). The signal dramatically decreased after 45 minutes of
stimulation and was no longer detectable after 90 minutes, which
correlates with the reported cytoplasmic relocalization of p65 in
MEFs after TNFa stimulation (Hoffmann et al., 2002). We also
performed the reciprocal experiment in p65–/– MEFs stably
complemented with wild-type (wt) and K310R p65.
Immunoprecipitation with anti-acetylated K310 (anti-acK310)
antibody from the nuclear extracts of TNFa-stimulated cells and
subsequent western blot analysis with an anti-p65 antibody showed
again that p65 was rapidly acetylated 20 minutes after TNFa
stimulation (Fig. 1D). Acetylation took place at K310 and was
specific, because the corresponding K310 acetylation mutant cells
displayed no acetylation signal at K310 on p65. Together, these
experiments revealed that p65 is acetylated at K310 in a TNFa-
dependent manner, possibly upon translocation to the nucleus.
p65 is deacetylated by SIRT1 and SIRT2 at K310 in vitro
The reversed acetylation of p65 prompted us to investigate which
enzyme might be responsible for p65 deacetylation at K310. Here
we focused on sirtuin proteins. To elucidate which sirtuin can
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Fig. 1. Kinetics of p65 K310 acetylation upon TNFa stimulation.
(A,B)Characterization of specific antibody against p65 acetylated at K310.
(A)Purified recombinant p65 wild type and the acetylation-deficient mutants
were incubated with recombinant p300 in the presence (+) or absence (–) of
acetyl CoA. Proteins were resolved by SDS-PAGE and analyzed by western
blot using the indicated antibodies. (B)HEK293T cells were transfected with
p65 wild type or mutants, with (+) or without (–) p300 co-transfection.
Acetylation of p65 at specific K310 was assessed by western blot using the
specific antibody. (C,D)Endogenous p65 is rapidly and possibly transiently
acetylated in the nucleus upon TNFa stimulation in vivo. (C)Wild-type p65
complemented MEFs were treated with TNFa for the indicated time periods.
p65 was immunoprecipitated from nuclear extracts and analyzed by western
blot using anti-acetyl K310 antibody. PARP1 from 5% input was used as
nuclear loading control. (D)Wild-type or K310R p65 complemented MEFs
were treated with TNFa for the indicated time periods. Acetyl K310 was
immunoprecipitated from nuclear extracts and analyzed by western blot using
anti-p65 antibody. PARP1 from 2.5% input was used as nuclear loading control.
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deacetylate p65 at K310, we purified (baculovirus expressed)
recombinant SIRT1, SIRT2, SIRT6 and SIRT7, which are known
to localize either to the nucleus or to the cytoplasm (Fig. 2A).
Recombinant purified p65 was acetylated in vitro by p300 and
subsequently incubated with purified recombinant SIRT1, SIRT2,
SIRT6 and SIRT7, in the presence or absence of NAD+. Although
SIRT2 was able to deacetylate p65 completely after 30 minutes, as
observed by western blot analysis using the anti-acK310 antibody,
SIRT1 was only able to do so after extended incubation (Fig. 2B
and supplementary material S1A). SIRT6 and SIRT7 were not able
to deacetylate p65 under the tested conditions.
p65 is deacetylated by SIRT2 at K310 in vivo
Since SIRT1 has been previously reported to deacetylate p65 (Yeung
et al., 2004), we decided to focus on SIRT2. To confirm that SIRT2
is also able to deacetylate p65 in vivo, His-tagged SIRT2 and
SIRT6 or SIRT7 (as negative controls) were overexpressed in
HEK293T cells (supplementary material Fig. S1B), along with
Myc-tagged p65. Stimulation of transfected cells with TNFa for 30
minutes resulted in effective acetylation of p65 K310 (Fig. 2C,
mock sample). Notably, overexpression of SIRT2 significantly
reduced p65 acetylation at K310, whereas SIRT6 and SIRT7 were
not able to deacetylate p65 under these conditions (Fig. 2C).
Similarly, overexpressing class I HDACs HDAC1, HDAC2 and
HDAC3 was insufficient to deacetylate K310 of p65 (supplementary
material Fig. S1C,D). To verify that the deacetylase activity of
SIRT2 was necessary for p65 deacetylation, we overexpressed the
wt and a catalytically inactive mutant of SIRT2 (H187Y), with p65
in HEK293T cells (Fig. 2D). The enzymatically inactive SIRT2
mutant was, as expected, unable to deacetylate p65 at K310. These
findings indicate that SIRT2 is able to deacetylate K310 of p65 in
cells. We have previously shown that p65 is acetylated by p300 at
K314 and K315 (Buerki et al., 2008). We also tested whether SIRT2
was able to deacetylate p65 at these residues. SIRT2 could
deacetylate p65 at K314 and K315 in vitro and in HEK293T cells
when overexpressed with p65 and p300 (supplementary material
Fig. S1E,F). However, antibodies raised against acetylated K314
and K315 did not recognize endogenous p65 and therefore we
concentrated on K310 acetylation of p65 for further investigations.
TNFa stimulation does not induce nuclear translocation of
SIRT2
Next, we decided to investigate whether SIRT2 translocates to the
nucleus upon TNFa stimulation. Since endogenous SIRT2 could
not be detected by immunofluorescence, we overexpressed HA-
tagged SIRT2 in HeLa cells and stimulated the cells with TNFa
for 30 or 90 minutes. Immunofluorescence studies revealed that
overexpressed SIRT2 and endogenous p65 localized to the
cytoplasm in untreated cells (Fig. 3A). After 30 minutes of TNFa
stimulation, p65 translocated to the nucleus and relocated to the
cytoplasm after 90 minutes, whereas SIRT2 remained in the
cytoplasm throughout the experiment, indicating that SIRT2 does
not shuttle to the nucleus upon TNFa stimulation (Fig. 3A).
SIRT2 forms a complex with p65 in the cytoplasm, which
is enhanced by TNFa stimulation
To investigate whether endogenous SIRT2 and p65 interact in
vivo, p65 was immunoprecipitated from cytoplasmic or nuclear
extracts of THP1 cells. Interestingly, SIRT2 coimmunoprecipitated
with p65 in the cytoplasmic extracts under basal conditions,
indicating that p65 forms a complex with SIRT2 in untreated cells
(Fig. 3B). Although TNFa stimulation induced nuclear translocation
of p65, enhanced p65–SIRT2 complex formation was observed in
the cytoplasmic fraction (Fig. 3B). SIRT2 did not
immunoprecipitate with nuclear p65, confirming that TNFa did
not induce SIRT2 translocation.
SIRT2 deacetylates p65 at K310 in the cytoplasm
To provide further evidence that SIRT2 deacetylates p65 in the
cytoplasm, HEK293T cells were transfected with expression
plasmids for different SIRT2 mutants containing an additional
NLS or an NLS in combination with a NES deletion (NLSDNES).
Whereas wild-type SIRT2 was located exclusively in the cytoplasm,
fusion of an NLS to SIRT2 slightly increased its nuclear localization
(Fig. 3C). Complete nuclear localization of SIRT2 could be
observed only upon additional deletion of the NES (NLSDNES
mutant). Importantly, analysis of the p65 acetylation status under
these conditions revealed that the nuclear localization of SIRT2
negatively correlated with p65 deacetylation (Fig. 3D). The
mutation of SIRT2 to achieve nuclear localization (SIRT2
NLSDNES mutant) did not abolish its deacetylation activity,
because it was able to efficiently deacetylate H4K16 in the nucleus
(supplementary material Fig. S2A,B). Collectively, these results
suggest that SIRT2 interacts with and deacetylates p65 exclusively
in the cytoplasm.
Hyperacetylation of p65 at K310 in Sirt2–/– cells
To further investigate the role of SIRT2 in p65 deacetylation in
vivo, Sirt2–/– and Sirt2+/+ MEFs were stimulated with TNFa and
4253SIRT2 deacetylates NF-kB
Fig. 2. SIRT2 deacetylates p65 at K310. (A)Expression and purification of
His-tagged SIRT1, SIRT2, SIRT6 or SIRT7 from insect cells. (B)In vitro
acetylated p65 wild type was incubated for 30 minutes with recombinant
sirtuins in the presence (+) or absence (–) of NAD+. Deacetylation was
confirmed by western blot analysis using the acK310-specific antibody.
(C)Overexpressed SIRT2 deacetylates p65 at K310 in HEK293T cells.
HEK293T cells were transfected with the expression plasmids for the
indicated His-tagged SIRT proteins with p300 and Myc-tagged p65. Whole-
cell extracts were prepared after 30 minutes of TNFa stimulation and analyzed
by western blot. (D)Deacetylase activity of SIRT2 is required for p65
deacetylation in cells. SIRT2 wild type or the enzymatic inactive mutant was
overexpressed in HEK293T cells with p300 and Myc-tagged p65. The
acetylation status of p65 after 30 minutes of TNFa stimulation was assessed
with the indicated antibody.
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acetylation of endogenous p65 was analyzed by western blot. The
increase in acetylation of endogenous p65 at K310 upon TNFa
stimulation was substantially larger in Sirt2–/– compared with wild-
type MEFs (Fig. 4A). Protein levels of SIRT1 were not altered in
the analyzed MEFs (Fig. 4B). Moreover, Sirt1–/– MEFs did not
display hyperacetylated p65 (supplementary material Fig. S3A).
Together, these results provide strong evidence that SIRT2 is the
predominant enzyme involved in deacetylation of p65 at K310
after TNFa stimulation in vivo.
SIRT2 regulates NF-kB-dependent gene expression
Since p65 acetylation influences NF-kB-dependent transcription, we
decided to investigate whether depletion of SIRT2 affects the
expression of NF-kB target genes upon TNFa stimulation in vivo.
We analyzed the expression of Mpa2l, a gene previously identified
to be dependent on NF-kB (Rothgiesser et al., 2010), which requires
acetylation of p65 at K310 for its transcriptional activation
(supplementary material Fig. S3B). Gene expression analysis by
real-time RT-PCR in Sirt2+/+ and Sirt2–/– MEFs uncovered a dramatic
increase in Mpa2l expression in Sirt2–/– cells compared with Sirt2+/+
cells in response to TNFa (70-fold difference, Fig. 4C). The same
was not observed for the control Rela, a gene that has not been
reported to be dependent on NF-kB or to be a housekeeping gene
(www.nf-kb.org) (Fig. 4D). Moreover, knockdown of p65 in
Sirt2–/– cells reduced the induction of Mpa2l expression
(supplementary material Fig. S3C,D). Transient knockdown of Sirt2
with siRNA in MEFs also enhanced Mpa2l expression, although not
to the same extent as in Sirt2–/– cells (Fig. 4E,F). This correlated with
our results showing that acetylation of p65 at K310 is required for
transcriptional activation of Mpa2l (supplementary material Fig.
S3B) and that p65 is hyperacetylated in Sirt2–/– MEFs (Fig. 4A). In
addition, we tested whether more NF-kB target genes, other than
Mpa2l, were expressed to a greater extent in Sirt2–/– cells upon
TNFa stimulation. Real-time RT-PCR analysis of 12 more NF-kB
target genes, revealed that half of the tested genes were expressed at
least twofold more in Sirt2–/– cells than in Sirt2+/+ cells upon TNFa
stimulation (Table 1). These data imply that there is a subset of NF-
kB target genes that are particularly dependent on K310 acetylation
and that inability to deacetylate p65 K310 is associated with greatly
increased gene induction, as observed in Sirt2–/– cells.
Sirt2–/– MEFs display resistance to TNFa-induced
apoptosis
Finally, we questioned the physiological relevance of enhanced
gene expression in Sirt2–/– MEFs after TNFa stimulation. p65–/–
MEFs are sensitive to TNFa-induced apoptosis (Beg and Baltimore,
4254 Journal of Cell Science 123 (24)
Fig. 3. SIRT2 deacetylates p65 in the cytoplasm. (A)p65
translocates to the nucleus in response to TNFa stimulation,
whereas SIRT2 stays in the cytoplasm. HeLa cells were transfected
with HA-tagged SIRT2 and stimulated with TNFa for the indicated
time points, followed by immunofluorescence detection of p65 and
HA-SIRT2. Nuclei are counterstained with DAPI. Subcellular
localization of p65 and HA–SIRT2 was analyzed with a confocal
microscope. (B)p65 interacts with SIRT2 in the cytoplasm. THP1
cells were stimulated with TNFa for the indicated time points. p65
was immunoprecipitated from nuclear and cytoplasmic extracts and
analyzed by western blot using indicated antibodies. Levels of
PARP1 as nuclear control are shown. (C)HEK293T cells were
transfected with HA-tagged SIRT2 wild type, NLS mutant or
NLSDNES mutant. After 30 minutes of TNFa stimulation, cells
were fixed and immunostained with anti-HA antibody to display
cellular localization of SIRT2 wild type and mutant proteins,
assessed with a confocal microscope. (D)Strongly reduced
decatylation of p65 acK310 upon overexpression of nuclear SIRT2
mutant. The same constructs as in C were overexpressed in
HEK293T cells along with p65 wild type and p300, followed by 30
minutes of TNFa stimulation, whole-cell extracts preparation and
western blot analysis with the indicated antibodies.
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1996). This encouraged us to stimulate Sirt2–/– and Sirt2+/+ MEFs
with TNFa (100 ng/ml) and measure Caspase-3 activity as a
marker for apoptosis. We used Camptothecin (CPT) (50 mM) as a
positive control. Stimulation of cells with CPT lead to significant
increase in Caspase-3 activity and was at least 15 times more than
the signal obtained from TNFa-stimulated samples (Fig. 4G).
There was no significant difference between the cell lines. However,
stimulation with TNFa led to a differential response. Whereas
Sirt2+/+ cells displayed a ~30% increase in Caspase-3 activity
upon TNFa induction, Sirt2–/– cells were protected from TNFa-
induced Caspase-3 activation (Fig. 4H). These results suggest that
Sirt2–/– cells are protected from TNFa-induced apoptosis and this
might be due to enhanced NF-kB gene induction, which we
observed in these cells (Table 1).
Discussion
We have previously shown that p65 acetylation has an important
role in the regulation of NF-kB-dependent transcription for a subset
of target genes. Here we identify SIRT2 as a p65 deacetylase.
SIRT2 deacetylates p65 in vitro and when overexpressed in cells
after TNFa stimulation. Furthermore, endogenous p65 and SIRT2
interact in the cytoplasm of unstimulated cells. Subsequent TNFa
treatment does not trigger SIRT2 translocation to the nucleus, but
enhances complex formation with p65 after 30 to 60 minutes, thus
indicating that it deacetylates p65 in the cytoplasm. Moreover, p65
is hyperacetylated at K310 in Sirt2–/– MEFs, which correlates with
a strong increase in expression of Mpa2l, a gene that is dependent
on the acetylation of p65 at K310.
We observed that p65 was rapidly acetylated at K310 in the
nucleus of MEFs upon TNFa stimulation and that the signal was
drastically reduced after 45 minutes of TNFa treatment (Fig. 1C).
Immunostaining and EMSA experiments have previously shown
that the majority of NF-kB shuttles back to the cytoplasm between
30 to 60 minutes after TNFa stimulation in MEFs (Buerki et al.,
2008; Hoffmann et al., 2002). Strikingly, the timing of p65
deacetylation at K310 correlates with its reported export to the
cytoplasm, supporting the idea that p65 is deacetylated in the
cytoplasm.
HDAC3 and SIRT1 have been previously described to
deacetylate p65 (Chen et al., 2001; Yeung et al., 2004). However,
we did not detect p65 deacetylation by overexpressed HDAC3 in
HEK293T cells. This discrepancy might be due to different
experimental procedures, such as the use of HEK293T cells instead
of COS-7 cells. Deacetylation of K310 by SIRT1 was shown in
vitro with recombinant proteins and in HEK293T cells with
4255SIRT2 deacetylates NF-kB
Fig. 4. Lack of SIRT2 increases TNFa-induced NF-kB-dependent
transcriptional activation. (A)Endogenous p65 is hyperacetylated in Sirt2–/–
cells. MEFs from the indicated genotypes were pre-treated with the HDAC
inhibitors (HDACi) TSA and Nam for 30 minutes and then stimulated with
TNFa for 1 hour before preparing whole-cell extracts. Extracts were analyzed
by western blot using anti-acK310 antibody. The membrane was reprobed for
p65, and tubulin was used as loading control. * indicates a non-specific band.
(B)Western blot analyses for endogenous SIRT1 and SIRT2 in Sirt2–/– cells.
Tubulin was used as loading control. Gene induction of Mpa2l (C) and Rela (D)
in Sirt2+/+ and Sirt2–/– MEFs after 3 hours of TNFa stimulation, as measured by
real-time RT-PCR. At least two biological replicates were analyzed. Shown are
the means ± s.d. of three independent runs. (E,F)Knockdown of Sirt2 increases
gene induction of Mpa2l. p65–/– MEFs stably complemented with wild-type p65
were transiently transfected with the indicated siRNA oligos, stimulated with
TNFa for 3 hours and Sirt2 levels (E) and gene induction of Mpa2l (F) was
analyzed by real-time RT-PCR. (G,H)Caspase-3 activity assay in Sirt2–/– and
Sirt2+/+ MEFs. Cells were treated with one of the following: 100 ng/ml TNFa or
50mM Camptothecin. After 20 hours the cells were harvested by slow speed
centrifugation and analyzed for the Caspase-3 activity assay using a plate reader.
The experiment was performed twice and results from one experiment
performed in triplicate are shown. (G)RFU relative signals as obtained from the
plate reader. (H)Percentage increase in RFU calculated as increase in signal after
TNFa treatment relative to the untreated sample.
Table 1. Fold induction of NF-kB target genes upon TNFa
stimulationa
Sirt2–/– Sirt2+/+
Cxcl5 318 46
Ccl20 488 56
Il6 26 4
Ip10 21083 75
Mmp9 63 9
Mmp13 4.7 1.2
Cxcl2 36 31
Cox2 1.3 0.9
Ikba 20.3 15
Mcp1 913 693
Lif 20.7 11.4
Gadd45b 1.9 2.9
aSirt2–/– and Sirt2+/+ MEFs were stimulated with TNFa for 3 hours and
gene expression was measured by real-time RT-PCR. Results are means of
three independent experiments.
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overexpressed proteins, which correlates with our results; however,
the latter might be the consequence of overexpressing the proteins.
Hyperacetylation of K310 upon TNFa stimulation in the Sirt2–/–,
but not Sirt1–/– MEFs suggests that SIRT2, but not SIRT1, is
crucial to deacetylate K310 of p65 in cells. Our experiments with
Sirt1–/– cells are in agreement with observations where RNAi of
SIRT1 did not lead to changes in NF-kB target gene expression,
unless cells were treated with resveratrol (Yeung et al., 2004).
These results suggest that SIRT1 and SIRT2 might function
independently in p65 deacetylation and do not exclude a role for
SIRT1 in the deacetylation of other lysines in p65. Recently, a
study showed that SIRT6 does not deacetylate p65 in vitro or in
vivo, in agreement with our results (Fig. 2B,C), but deacetylates
histone H3K9 to attenuate NF-kB signaling (Kawahara et al.,
2009).
Gene expression analysis of Sirt2–/– MEFs revealed that
transcriptional activation of Mpa2l, whose expression was
dependent on p65 acetylation at K310 (supplementary material
Fig. S3B), was dramatically increased in Sirt2–/– cells compared
with another gene, Rela, whose expression does not depend on
K310 acetylation (Fig. 4D). This effect was not just restricted to
Mpa2l. Our extended real-time PCR analysis on 12 other NF-kB
target genes revealed six of the tested genes to be more inducible
upon TNFa stimulation in Sirt2–/– cells compared with Sirt2+/+
cells (Table 1). Therefore, we propose that SIRT2 regulates the
expression of a subset of NF-kB-dependent genes by
deacetylating p65 at K310 in the cytoplasm upon relocation of
NF-kB to this cellular compartment after the first wave of NF-
kB induction. Since NF-kB is known to shuttle between nucleus
and cytoplasm in 30–60 minutes in MEFs upon continuous
TNFa stimulation (Hoffmann et al., 2002), p65 would be
hyperacetylated in Sirt2–/– cells after 3 hours of TNFa treatment,
which would explain the observed differential Mpa2l gene
regulation.
Crosstalk between deacetylation at K310 and other post-
translational modifications on p65 has to be investigated further.
For example, phosphorylation of p65 at S276 was reported to
enhance its interaction with its transcriptional coactivator
CBP/p300 and with components of the general transcription
machinery (Zhong et al., 2002). High-resolution microscopy
revealed very recently that S536-phosphorylated p65
predominantly localized in the cytosol (Moreno et al., 2010). It
is therefore possible that other post-translational modifications of
p65 (e.g. phosphorylation of S536) also regulate the formation of
complexes of SIRT2 and p65.
Increased gene response after TNFa stimulation in Sirt2–/– MEFs
might have physiological relevance. Caspase-3 activity assay
revealed that Sirt2–/– MEFs are more resistant to TNFa-induced
apoptosis. After 20 hours of TNFa stimulation, Sirt2–/– MEFs
showed less than 0.5% increase in caspase-3 activity, whereas
Sirt2+/+ MEFs displayed a ~30% increase in caspase-3 activity
(Fig. 4H). Thus, it could be envisioned that enhanced NF-kB
activity in Sirt2–/– MEFs protects from TNFa-induced apoptosis
and has physiological relevance in NF-kB-mediated survival
pathways. We also observed that Sirt2–/– MEFs proliferate more
slowly than Sirt2+/+ MEFs (data not shown). This suggests that
there are other target transcriptional factors of SIRT2, such as E2F,
which has been shown to be important for cell proliferation (Polager
et al., 2002).
Despite the identification of p65 acetylation, the exact
mechanism by which p65 K310 acetylation regulates the expression
remains to be further elucidated. Huang and colleagues reported
that the double bromodomain of Brd4 binds to acetylated K310,
which enhances transcriptional activation of NF-kB and the
expression of a subset of NF-kB inflammatory genes in an
acetylated-K310-dependent manner (Huang et al., 2008).
Our data suggest that in unstimulated cells, SIRT2 exists in a
complex with p65. Upon TNFa stimulation, p65 translocates to
the nucleus, whereas SIRT2 stays in the cytoplasm. Coactivator
p300 binds to nuclear p65 and acetylates it at K310, K314 and
K315 to fine-tune gene expression. Once the NF-kB response is
terminated, p65 shuttles back to the cytoplasm, where SIRT2
deacetylates p65 at K310, thereby resetting the whole NF-kB
response. Any p65 that would afterwards translocate to the nucleus
again during continuous TNFa stimulation would have to be freshly
acetylated by p300 to modulate gene expression, thereby allowing
a tight control of NF-kB-dependent transcription.
Together, our results identify SIRT2 as a deacetylase of NF-kB
and an important regulator of TNFa-induced NF-kB-dependent
gene expression.
Materials and Methods
Tissue culture
Complemented p65–/– NIH3T3 mouse embryonic fibroblasts (MEFs) stably
expressing p65 wild type or the acetylation-deficient mutants were previously
described (Buerki et al., 2008). They were maintained in DMEM supplemented with
10% FCS, 100 U/ml penicillin-streptomycin (Gibco) and non-essential amino acids
(Gibco). Sirt2–/– and Sirt2+/+ MEFs were a generous gift from Alejandro Vaquero
(IDIBELL, L’Hospital et de Llobregat, Barcelona, Spain). Those cells were originally
generated in the lab of Fred Alt, HHMI, Boston, MA (Vaquero et al., 2006). Sirt1–/–
and Sirt1+/+ MEFs were kindly provided by F. Alt (Cheng et al., 2003). Sirt1–/–,
Sirt1+/+, Sirt2–/– and Sirt2+/+ MEFs were kept in DMEM supplemented with 15%
FCS, 100 U/ml penicillin-streptomycin (Gibco), non-essential amino acids (Gibco),
b-mercaptoethanol (Gibco) and sodium pyruvate (Gibco). HEK293T and HeLa cells
were maintained in DMEM supplemented with 10% FCS and 100 U/ml penicillin-
streptomycin. THP1 cells were maintained in RPMI medium containing 10% FCS,
100 U/ml penicillin-streptomycin (Gibco), non-essential amino acids (Gibco), b-
mercaptoethanol (Gibco) and sodium pyruvate (Gibco).
Plasmids
Plasmids for the mammalian expression of human p65 wild type and mutants
K310R, K314/315R and KTR are described elsewhere (Buerki et al., 2008).
Mammalian expression plasmids of human SIRT1, SIRT2, SIRT6 and SIRT7 in the
pcDNA-DEST40-V5/HIS background were kindly provided by Izumi Horikama,
NCI, NIH, Bethesda, MD (Michishita et al., 2005). The enzymatic inactive mutant
was generated by site-directed mutagenesis of H187 to Y with pcDNA-DEST40-
SIRT2 as template. The introduced mutation was verified by DNA sequencing.
Plasmids for the expression of HA-tagged SIRT2 and HA vector control were
described elsewhere (Pandithage et al., 2008). The GW-pHA-SIRT2-NLS vector
was created by cloning the sequence 5-GATCCCCAAAGAAGAAGCGAAAGG -
TAC into GW-pHA-SIRT2. Site-directed mutagenesis was performed to change the
SIRT2 K4 and K12 to alanines, creating the GW-pHA-SIRT2-NLSDNES vector.
The introduced sequence and mutations were verified by DNA sequencing.
Reagents and antibodies
Human tumor necrosis alpha (TNFa), Trichostatin A (TSA), Nicotinamide (Nam)
and acetyl-Coenzyme A (acetyl Co-A) were purchased from Sigma. Recombinant
mouse TNFa was either purchased from Sigma or generated in our laboratory.
Sodium fluoride (NaF) and b-glycerophosphate were obtained from Fluka. The
acetyl-specific antibodies for p65 anti-acetyl K310 (ab19870), anti-acetyl K314
(ab18727) and anti-acetyl K315 (19869) were generated by Abcam. The following
antibodies were purchased from Santa Cruz Biotechnologies: anti-p65 (sc-372), anti-
p300 (sc-585) and anti-SIRT2 (sc-20966 and sc-28298). The anti-SIRT1 antibody
was from Millipore (07-131). The anti-Myc antibodies were either purchased from
Roche (11-667-149-001) or purified from hybridoma cells. The anti-tubulin antibody
was purchased from Sigma (T6199), the anti-His was from Qiagen (34670) and the
anti-HA was from Covance (MMS-101P). Caspase-3 activity assay was purchased
from Calbiochem (QIA70).
Generation of recombinant proteins
The recombinant proteins were expressed by baculovirus in Sf21 cells using either
the FastBac or the BacPAK systems (Clontech). His-tagged proteins were purified
over Ni2+ beads (ProBond, Invitrogen) and GST-tagged proteins over L-Glutathione
beads (Sigma).
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In vitro acetylation assay
1 mg of recombinant p65 wild type or the acetylation-deficient mutants were
incubated with 500 ng recombinant p300 in HAT buffer (50 mM Tris-HCl, pH 8,
100 mM NaCl, 10% glycerol, 1 mM PMSF, 1 mM DTT, 1 mg/ml bepstatin, 1 mg/ml
leupeptin, 1 mg/ml pepstatin and 1 mM sodium butyrate) with or without addition of
150 mM acetyl-CoA. After 1 hour at 30°C, samples were resolved on SDS-PAGE
and analyzed by western blot.
In vitro deacetylation assay
500 ng recombinant p65 wild type was in vitro acetylated as described previously
and then immunoprecipitated. The bead-bound p65 was incubated with 14 pmol of
each recombinant SIRT in 100 ml deacetylation buffer (50 mM Tris-HCl, pH 9,
4 mM MgCl2, 0.2 mM DTT, 1 mg/ml bepstatin, 1 mg/ml leupeptin and 1 mg/ml
pepstatin) supplemented or not with 1 mM NAD+ for 30 minutes or 2 hours with
constant agitation. Proteins were subsequently resolved in SDS-PAGE and analyzed
by western blot. Purified recombinant SIRTs were additionally resolved on SDS-
PAGE and stained with Coomassie Blue.
Acetylation and deacetylation assays in cells
HEK293T cells were transfected with expression plasmids for p300 and either Myc-
tagged p65 wild type, the acetylation-deficient mutants or an empty vector, using the
calcium phosphate precipitation method. After 23 hours, cells were treated with 10
ng/ml human TNFa for 30 minutes. Then, whole-cell extracts were prepared and 40
mg protein was analyzed by SDS-PAGE and western blot. For the deacetylation
assay in cells, 0.1 pmol expression plasmid encoding the different sirtuins (wild type
or mutants) or empty vector were additionally co-transfected in HEK293T cells.
Immunostaining
Transfected HEK293T cells or HeLa cells were stimulated with 10 ng/ml human
TNFa for 30 minutes. They were fixed with 4% paraformaldehyde and then
permeabilized with 0.2% Triton X-100. Blocking solution (2% BSA and 0.1% Triton
X-100 in PBS) was added for 1 hour before the slides were incubated with anti-HA
and anti-p65 antibodies (1:250 each in blocking solution), followed by incubation
with FITC-labeled anti-mouse and Cy3-labeled anti-rabbit antibodies (1:250 each in
blocking solution, Jackson ImmunoResearch). The slides were washed, covered with
Vectashield mounting solution (Vector Laboratories) and visualized using a Leica
SP5 confocal microscope.
Caspase-3 activity assay
Caspase-3 activity assay was performed according to manufacturer’s instructions
(Calbiochem). Briefly, 7103 cells were seeded on 96-well plates. 5 hours after
seeding, cells were stimulated with TNFa (100 ng/ml) or campotethcin (50 mM).
After 20 hours of stimulation, cells were centrifuged on the plates and analyzed for
caspase-3 activity using microplate Reader Tecan Infinite 200.
Nuclear and cytoplasmic extract preparation and immunoprecipitation
THP1 cells were stimulated with 10 ng/ml TNFa for the indicated time periods,
harvested, washed once with PBS, and washed three times in buffer A (10 mM
HEPES-KOH, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mg/ml pepstatin, 1 mg/ml
bestatin, 1 mg/ml leupeptin, 2 mM PMSF, 5 mM DTT). Cells were lysed with A+
buffer (Buffer A+ 0.05% NP-40) and centrifuged for 5 minutes at 5000 r.p.m.
Supernatant corresponding to cytoplasm was saved and kept on ice until the nuclear
fraction was ready. The pellet was washed three times with buffer A and subsequently
resuspended in three volumes of Buffer C (20 mM HEPES-KOH, pH 7.9, 0.42 M
NaCl, 1.5 mM MgCl2, 25% v/v glycerol, 1 mg/ml pepstatin, 1 mg/ml bestatin,
1 mg/ml leupeptin, 2 mM PMSF, 5 mM DTT) and incubated for 15 minutes at 4°C
on rotating wheels. Lysate was centrifuged for 10 minutes at 4°C at 14,000 r.p.m.
and the supernatant corresponding to nuclear extract was separated for
immunoprecipitation. 150 mg nuclear extracts or 450 mg cytoplasmic extracts were
mixed with IP buffer (20 mM HEPES-KOH, pH 7.9, 2.5 mM MgCl2, 0.1% NP-40,
50 mM NaCl, 1 mg/ml pepstatin, 1 mg/ml bestatin, 1 mg/ml leupeptin, 2 mM PMSF)
in a final of 120 mM NaCl concentration, 2.5% of the mix was saved for the input
analysis. p65 antibody was added and incubated for 2 hours at 4°C on a roller. At
the end of the incubation, prewashed protein-G beads were added to the mix for
another 2 hours. Finally, beads were washed three times with IP buffer containing
120 mM NaCl. Beads and the inputs were added Laemmli buffer, boiled and resolved
on SDS-PAGE and subjected to western blot using different antibodies.
Gene expression by real-time RT-PCR
Complemented MEFs were starved overnight before treatment with 30 ng/ml
recombinant TNFa for different time points. Sirt2+/+ and Sirt2–/– MEFs were starved
for 6 hours and then stimulated with 30 ng/ml recombinant TNFa for 3 hours or left
unstimulated. Total RNA was isolated from at least two biological samples at
different days with the ‘Total RNA isolation mini kit’ (Agilent Technologies). RNA
was subsequently retro-transcribed using the ‘High-capacity cDNA reverse
transcription kit’ (Applied Biosystems). Real-time PCR was performed using the
Rotor-Gene 3000 (Corbett Life Science, now Qiagen) and TaqMan assays from
Applied Biosystems for Mpa2l, Mmp13, Rps6 and CanX genes. The last two genes
were used as internal controls to normalize for RNA input. In addition, gene
expression of Mpa2l, Mmp13, Rela and Rps12 (as internal control) was assessed
with SYBR Green using the primers listed in supplementary material Table S1. RNA
from at least two biological replicates per sample was measured and analyzed with
REST (Pfaffl et al., 2002). Each experiment was run independently three times, the
mean value ± s.d. was calculated and plotted. Expression of genes presented in Table
1 was measured with real-time RT-PCR with SYBR Green primers listed in
supplementary material Table S1.
Transient transfections
MEF cells were seeded on six-well tissue culture plates and next day transfected
with 30 pmol siRNA oligos (Qiagen) with 4 ml Lipofectamine RNAimax reagent
(Invitrogen) according to the manufacturer’s protocol for 2 days.
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